NadiaEwingMD

PubMed

• 5 citations
  Hemophilia A Inhibitor Subjects Show Unique PBMC Gene Expression Profiles That Include Up-Regulated Innate Immune Modulators.
  Ahmad Faisal Karim, Anthony R. Soltis, Gauthaman Sukumar, Christoph Königs, Nadia P. Ewing, Clifton L. Dalgard, Matthew D. Wilkerson, Kathleen P. Pratt> ;Frontiers in Immunology. 2020 Jun 12
• 3 citations
  Transfusion of multiple units of Js(b+) red blood cells in the presence of anti-Jsb in a patient with sickle beta-thalassemia disease and a review of the literature.
  Shan Yuan, Nadia P. Ewing, Debra Bailey, Marissa Salvador, Shirong Wang> ;Immunohematology. 2020 Apr 1
• 20 citations
  Prophylaxis with FEIBA in paediatric patients with haemophilia A and inhibitors.
  Nadia P. Ewing, Carmen Escuriola-Ettingshausen, W. Kreuz> ;Haemophilia. 2015 May 1
• 23 citations
  Consequences of switching from prophylactic treatment to on-demand treatment in late teens and early adults with severe haemophilia A: the TEEN/TWEN study.
  Marilyn J. Manco-Johnson, J. Sanders, Nadia P. Ewing, Nidra I Rodriguez, Michael D. Tarantino, Thomas J. Humphries, Teen> ;Haemophilia. 2013 Sep 1
• 7 citations
  Understanding FVIII/VWF complex--report from a symposium of XXIX WFH meeting 2010.
  Alessandro Gringeri, Frederick A. Ofosu, S. Grancha, Johannes Oldenburg, Nadia P. Ewing, Augusto B. Federici> ;Haemophilia. 2012 May 1
• 4 citations
  von Willebrand factor: what is its role in the immune response in haemophilia?
  Srini V. Kaveri, P. M. Mannucci, Margaret Heisel Kurth, Nadia P. Ewing, Craig M. Kessler, Diane J. Nugent, Edward D. Gomperts> ;Haemophilia. 2011 Jan 1
• 19 citations
  Identifying non-responsive bleeding episodes in patients with haemophilia and inhibitors: a consensus definition.
  Erik Berntorp, Peter William Collins, Roseline d'Oiron, Nadia P. Ewing, Alessandro Gringeri, Claude Negrier, Guy Young> ;Haemophilia. 2011 Jan 1
• 21 citations
  Bleeding symptoms and laboratory correlation in patients with severe von Willebrand disease.
  Ara Metjian, C. Wang, Suman L. Sood, Adam Cuker, S. M. Peterson, J. M. Soucie, Barbara A. Konkle, Marjorie A. Boyd, Glen Roy, Edwin N. Forman, Jean Marandola, Alan C. ...> ;Haemophilia. 2009 Jul 10
• 11 citations
  The application of bypassing-agent prophylaxis in haemophilia A patients with inhibitors: a meeting report
  Leonard A. Valentino, Manuel Carcao, Prasad Mathew, Cindy A. Leissinger, Erik Berntorp, V. Blanchette, Carmen Escuriola-Ettingshausen, Bruce M. Ewenstein, Nadia P. Ewi...> ;Haemophilia. 2009 Jul 1
• 15 citations
  Experience with a third generation recombinant factor VIII concentrate (Advate) for immune tolerance induction in patients with haemophilia A.
  Leonard A. Valentino, Michael Recht, Jorge DiPaola, Amy D. Shapiro, Steven W. Pipe, Nadia P. Ewing, J. Urgo, T. Bullock, M. Simmons, C. Deguzman> ;Haemophilia. 2009 May 1
• 49 citations
  Prophylactic treatment with activated prothrombin complex concentrate (FEIBA) reduces the frequency of bleeding episodes in paediatric patients with haemophilia A and ...
  Cindy A. Leissinger, D. L. Becton, Nadia P. Ewing, Leonard A. Valentino> ;Haemophilia. 2007 May 1
• 43 citations
  Therapeutic choices for patients with hemophilia and high-titer inhibitors
  Roshni Kulkarni, Louis M. Aledort, Erik Berntorp, Hans H. Brackman, Deborah L Brown, Alan R. Cohen, Nadia P. Ewing, Alessandro Gringeri, Ralph A. Gruppo, Keith Hoots, ...> ;American Journal of Hematology. 2001 Aug 1
• 64 citations
  Cerebral Vasculopathy in Sickle Cell Anemia: Diagnostic Contribution of Positron Emission Tomography
  Darleen R. Powars, Peter S. Conti, Wing-Yen Wong, Paula K. Groncy, Carol B. Hyman, Elaine Smith, Nadia P. Ewing, Robert N. Keenan, Chi-Shing Zee, Yvonne Harold, Alan L...> ;Blood. 1999 Jan 1
• 1 citations
  Comparative efficacy of nonheated and heat-treated factor IX complex concentrate in treatment of hemophiliacs with inhibitors.
  Richard S. Schwartz, Nadia P. Ewing, Toni J. Gorenc, Joel A. Spero> ;American Journal of Hematology. 1989 Jan 1
• 93 citations
  Induction of immune tolerance to factor VIII in hemophiliacs with inhibitors.
  Nadia P. Ewing, Natalie L. Sanders, Shelby L. Dietrich, Carol K. Kasper> ;JAMA. 1988 Jan 1
• 56 citations
  Hematologic Management of Hemophilia A for Surgery
  Carol K. Kasper, A. Lois Boylen, Nadia P. Ewing, James V. Luck, Shelby L. Dietrich> ;JAMA. 1985 Mar 1
• 21 citations
  Altered distribution of T-lymphocyte subpopulations in lymph nodes from patients with acquired immunodeficiency-like syndrome and hemphilia
  Paul R. Meyer, Robert L. Modlin, Darleen R. Powars, Nadia P. Ewing, John W. Parker, Clive R. Taylor> ;The Journal of Pediatrics. 1983 Sep 1
• 34 citations
  In vitro detection of mild inhibitors to factor VIII in hemophilia.
  Nadia P. Ewing, Carol K. Kasper> ;American Journal of Clinical Pathology. 1982 Jun 1
• Join now to see all

Journal Articles

• Consequences of Switching From Prophylactic Treatment to On Demand Treatment in Late Teens and Early Adults With Severe Hemophilia A: The TEEN/TWEN Study  
  Manco-Johnson, M, Sanders, J, Ewing, N, Rodriguez, N, Tarantino, Humphries, T and the TEEN/TWEN Study Group, Haemophilia, 1/1/2013
• Identifying Nonresponsive Bleeding Episodes in Patients with Hemophilia and Inhibitors: A Consensus Definition  
  Berntorp, E, Collins, P., D’Oiron, R., Ewing, N., Gringeri, A, Negrier, C., Young, G, Haemophilia, 1/1/2010
• The Application of Bypassing Agent Prophylaxis in Hemophilia A Patients with Inhibitors: a Meeting Report  
  Valentino, L.,Carcao, M.,Mathew, P., Leissinger, C., Berntorp, E., Blanchette, V., Escuriola-Ettingshausen, C., Ewenstein, B., Ewing. N.,Gringeri, A., Hoots, W., Negri..., Haemophilia, 1/1/2009
• Experience with a Third Generation Recombinant Factor VIII Concentrate (Advate) for Immune Tolerance induction in Patients with Hemophilia A  
  Valentino, L.,Recht,M.,DiPaola, J.,Shapiro, A.,Pipe, S., Ewing, N., Urgo, J.,Bullock, T.,Simmons, M., and Deguzman, C., Haemophilia, 1/1/2009
• Prophylactic treatment with activated prothrombin complex concentrate (FEIBA)reduces the frequency of bleeding episodes in paediatric patients with haemophilia A and i...  
  Leissinger, C.A.,Becton, D.L., Ewing, N.P., Valentino, L.A., Haemophilia, 1/1/2007
• Transfusion of multiple units of Js(b+) red cells in the presence of anti-Jsb in a patient with sickle beta thalassemia disease and a review of the literature  
  Yuan S, Ewing N.P., Bailey D, Salvador M, Wang S, Immunohematology, 1/1/2007
• Therapeutic Choices for Patients with Hemophilia and High-Titer Inhibitors  
  Kulkarni R., Aledort L., Berntorp E., Brackman H.H., Brown D., Cohen A.R., Ewing, N.P., Gringeri A., Gruppo R., Hoots K., Leissenger C., Peerlinck K., Poon M.-C., and ..., American Journal of Hematology, 1/1/2001
• Cerebral Vasculopathy in Sickle Cell Anemia: diagnostic contribution of positron emission tomography  
  Powars D., Conti P., Wong W., Groncy P., Hyman C., Smith E., Ewing N.P, Keenan R., Zee C., Harold Y., Hiti A., Teng E., Blood, 1/1/1999
• Induction of Immune Tolerance, the Future of the Registry Review  
  Ewing, N.P., Vox Sanguinis, 1/1/1996
• Immune tolerance as treatment of alloantibodies to factor VIII in hemophilia  
  Mariani G., Scheibel E., Nogao T., Kasper C.K., Ewing N.P., Mauser-Bunschoten E., Ghirardini A., Bellocco R., and Brackman H.H., for the participants in the Internatio..., Seminars in Hematology, 1/1/1994
• Induction of Immune Tolerance with Factor VIII Concentrate in Patients with hemophilia A and Inhibitors  
  Ewing, N.P., Prog Clin Biol Res, 1/1/1990
• Comparative Efficacy of Non-heated and Heat-Treated Factor IX Complex Concentrate in Treatment of Hemophiliacs with Inhibitors  
  Schwartz R.S., Ewing N.P., Gorenc T.J., and Spero J.A., American Journal of Hematology, 1/1/1989
• Induction of Immune Tolerance in Hemophiliacs with Inhibitors  
  Cattaneo M., Gringeri A., Mannucci P., Ewing, N.P., Sanders N.L., Dietrich S.L., Kasper C.K., JAMA, 1/1/1988
• Induction of Immune Tolerance to Factor VIII in Hemophiliacs with Inhibitors  
  Ewing N.P., Sanders N.L., Dietrich S.L., and Kasper C.K., JAMA, 1/1/1988
• Acquired Inhibitors of Plasma Coagulation Factors  
  Kasper C.K., & Ewing N.P., Journal of Medical Technology, 1/1/1986
• Hematologic Management of Hemophilia A for Surgery  
  Kasper C.K., Boylen A.L., Ewing N.P., Luck J.V., Dietrich S.L., JAMA, 1/1/1985
• Altered Distribution of T-Lymphocyte Sub-population in Lymph Nodes from Patients with Acquired Immunodeficiency-like Syndrome and Hemophilia  
  Meyer P.R., Modlin R.L., Powars D., Ewing N.P.., Parker J.W., & Taylor C.R., The Journal of Pediatrics, 1/1/1983
• In Vitro Detection of Mild Inhibitors to Factor VIII in Hemophilia  
  Ewing N.P., & Kasper C.K., American Journal of Clinical Pathology, 1/1/1982
• Neutrophilic Phagocytosis in Autoimmune Thrombocytopenia Purpura  
  Marshall G.J., Powars D., Ewing, N.P. & Kirchen M., American Journal of Pediatric Hematology/Oncology, 1/1/1982
• Issues Surrounding Genetic Screening Programs  
  Ewing, N.P., et al, American Journal of Public Health, 1/1/1981
• Newborn Diagnosis of Abnormal Hemoglobins from a Large Municipal Hospital in Los Angeles  
  Ewing, N.P., Powars D.R., Hilburn J., & Schroeder W.A., American Journal of Public Health, 1/1/1981
• Bacteremia, Arthritis and Skin Lesions Due to Kingella Kingae  
  Redfield D.C., Overturf G.D., Ewing, N.P., & Powars D.R., Arch Dis Childh, 1/1/1980
• Join now to see all

Books/Book Chapters

• Therapeutic Strategies to Prevent Joint Damage in Patients with Inhibitors to Factor VIII. 
  Becton, D.L., Ewing, N.P., Valentino, L.A.Editors: Leissinger, C.A..CME Monograph2005
• Progress in Clinical Biology and Medicine 
  Chapter: Induction of Immune Tolerance with Factor VIII Concentrate. 
  Ewing, N.P.1989
• Reach for Fitness. 
  Chapter: Malignant Bone Tumors 
  Ewing, N.P.Editors: R.L. Simmons.Warner Books, Inc.1986
• Methods in Haematology: The Haemophilias. 
  Chapter: Measurement of Inhibitor of Factor VIII:C (and IX:C) 
  Kasper C.K. & Ewing, N.P.Editors: A.L. Blood.Churchill Livingstone1982
• Managing Hemophilia with Factor VIII Inhibitor. 
  Chapter: Experience with the Bethesda Assay and Other Methods of Inhibitor Detection. Activated Prothrombin Complex Concentrates 
  Kasper C.K., & Ewing, N.P.Editors: G. Mariani, M.A. Russo & F. Mandelli.1982
• Join now to see all

Abstracts/Posters

• Hemophilia A Inhibitor Subjects Show Unique PBMC Gene Expression Profiles That Include up-Regulated Innate Immune Modulators
  Nadia P Ewing, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Current Evidence For Prophylaxis in Pediatric Patients With Inhibitors.
  Ewing, N.P., Latin American Hemophilia Study Update, Cartagena, Colombia, 1/7/2014
• Transition from Pediatric to Adult Panel
  Ewing, N.P., Region IX Hemophilia Treatment Center Annual Meeting, Santa Monica, CA, 1/29/2012
• Hemophilia Research in Southern California
  Ewing, N.P., Hemophilia Treatment Center Education Day, Los Angeles, CA, 1/12/2012
• Use of recombinant factor VIIa for Bleeding and Surgeryi n Glanzmann’s Thrombasthenia and Other Platelet Disorders: An Analysis from the Hemophilia and Thrombosis Rese...
  Chitlur, M., Ewing, N.,Kraut, E., Cooper, D., Annual Scientific Symposium of the Hemostasis and Thrombosis Research Society, Chicago, IL, 1/28/2011
• Consequences of Switching from Prophylactic Treatment to on Demand Treatment in Late Teens and Early Adults with Severe Hemophilia A. The TEEN/TWEN Study.
  Manco-Johnson, M., Sanders J., Ewing N., and the TEEN/TWEN Study Group, Annual Scientific Symposium of the Hemostasis and Thrombosis Research Society, Chicago, IL, 1/28/2011
• Recombinant Factor VIIa Use in Glanzmann’s Thrombasthenia and Other Platelet Disorders: Hemophilia and Thrombosis Research Society (HTRS) Registry Data.
  Chitlur, M., Ewing, N., Kraut, E., Cooper, D., XXIII Congress of the International Society Of Thrombosis and Hemostsis, Kyoto, Japan, 1/23/2011
• Consequences of Switching from Prophylactic Treatment to On Demand Treatment in Late Teens and Early Adults with Severe Hemophilia A.
  Manco-Johnson, M., Sanders J., Ewing N., XXIII Congress of the International Society Of Thrombosis and Hemostsis, Kyoto, Japan, 1/23/2011
• Management of Inhibitor Patients with High Risk of ITI Failure: RES.I.ST Study.
  Ewing, N.P., XXIX International Congress of the World Federation of Hemophilia. Understanding FVIII/VWF complex: from Science to the Patient, Buenos Aires, Argentina, 1/13/2010
• FVIII/VWF in Inhibitor Patients at Risk for ITI Failure, or who failed ITI with FVIII.
  Ewing, N.P., National Conference on Blood Disorders in Public Health, Atlanta, GA, 1/9/2010
• FVIII/VWF in Inhibitor Patients at Risk for ITI Failure, or who failed ITI with FVIII.
  Ewing, N., Gringeri, A., Heisel-Kurth, M., Negrier, C., Hoots, W.K., Proceedings of the National Conference on Blood Disorders in Public Health, Atlanta, GA, 1/9/2010
• Inhibidores; Celebracion #2 Taller Educativo de Hemofilia
  Ewing, N.P., Hemophilia Spanish Family Education Day, Montecillo de Leo Politi Park, Elysian Park, Los Angeles, CA, 1/2/2010
• Mis 30 Anos de Experiencia en Cuidado de Hemophilia (Key note Address)
  Ewing, N.P., Hemophilia Spanish Family Education Day, Montecillo de Leo Politi Park, Elysian Park, Los Angeles, CA, 1/2/2010
• VWF/FVIII Concentrates in High Risk Immunotolerance: The RESIST Studies.
  Gringeri, A, Ewing, N., Heisel-Kurth, M., Hoots, K, Negrier, C., ISTH, XXII Congress, Boston, MA, 1/11/2009
• Identifying Non Responsive Bleeding Episodes in Patients with Hemophilia and Inhibitors: a Consensus Definition.
  Young, G., Berntorp, E., Collins, P., D’Oiron, R., Ewing, N., Gringeri, A., Negrier, C., ISTH, XXII Congress, Boston, MA, 1/11/2009
• VWF/FVIII Concentrates in High Risk Immunotolerance: The RESIST Studies.
  Gringeri, A, Ewing, N., Heisel-Kurth, M., Hoots, K, Negrier, C., J Thromb Haemost, 1/1/2009
• Identifying Non Responsive Bleeding Episodes in Patients with Hemophilia and Inhibitors: a Consensus Definition.
  Young, G., Berntorp, E., Collins, P., D’Oiron, R., Ewing, N., Gringeri, A., Negrier, C., J Thromb Haemost, 1/1/2009
• A Phase II Open Label Study Evaluating the Hemostatic Activity and Safety of Recombinant Porcine Factor VIII (OBI-1) in Hemophilia A Patients with Inhibitors Directed ...
  Mahlangu,J., Andreeva, T.,MacFarlane, D.,Reding, M.,Walsh, C., Ewing, N., Kessler, C.,Kempton, C., Matthew, P., Plyushch, O., Shapiro, A., St Louis, J., Warrier, I., H..., XXVIII International Congress of the World Federation of Hemophilia Congress, Istanbul, Turkey, 1/1/2008
• Experience with a Third Generation Recombinant Factor VIII Concentrate (Advate) for Immune Tolerance induction in Patients with Hemophilia A.
  Valentino, L.,Recht,M.,DiPaola, J.,Shapiro, A.,Pipe, S., Ewing, N., Urgo, J.,Bullock, T.,Simmons, M.,Pipe, R, and Deguzman, C., XXVIII International Congress of the World Federation of Hemophilia Congress, Istanbul, Turkey, 1/1/2008
• A Phase II Open Label Study Evaluating the Hemostatic Activity and Safety of Recombinant Porcine Factor VIII (OBI-1) in Hemophilia A Patients with Inhibitors Directed ...
  Mahlangu,J., Andreeva, T.,MacFarlane, D.,Reding, M.,Walsh, C., Ewing, N., Kessler, C.,Kempton, C., Matthew, P., Plyushch, O., Shapiro, A., St Louis, J., Warrier, I., H..., Hemophilia, 1/1/2008
• Experience with a Third Generation Recombinant Factor VIII Concentrate (Advate) for Immune Tolerance induction in Patients with Hemophilia A.
  Valentino, L.,Recht,M.,DiPaola, J.,Shapiro, A.,Pipe, S., Ewing, N., Urgo, J.,Bullock, T.,Simmons, M.,Pipe, R, and Deguzman, C., Hemophilia, 1/1/2008
• Transfusion of multiple units of Js(b+) red cells in the presence of anti-Jsb in a patient with sickle beta thalassemia disease.
  Yuan S, Ewing N.P., Bailey D, Salvatore M, Wang S, American Association of Blood Banking Annual Meeting, Anaheim, CA, 1/20/2007
• A Phase II Open Label Study Evaluating Hemostatic Activity, Pharmakokinetics and Safety of Recombinant Porcine Factor VIII (OBI-1) in Hemophilia A Patients with Alloan...
  Mahlangu,J., Andreeva, T.,MacFarlane, D.,Reding, M.,Walsh, C., Ritchie, B., Ewing, N., Kessler, C.,Kempton, C., Libby, E., Zozulya, N., Shapiro, A., St Louis, J., Warr..., Blood, 1/16/2007
• Joint Preservation in Hemophiliacs with Inhibitors.
  Ewing, N.P., Hemophilia Family Information Day, sponsored by the So. CA Hemophilia Foundation, Police Academy, Los Angeles, CA, 1/14/2007
• Anamnesis in Patients with Hemophilia and Inhibitors who receive Activated Prothrombin Complex Concentrates for Prophylaxis.
  Ewing, N.P., De Guzman, C., Pullens, L, ISTH, XXI Congress, Geneva, Switzerland, 1/5/2007
• Join now to see all

Lectures

• The OB/GYN’s Role in von Willebrand Disease (VWD) Detection. 
  Pasadena, CA - 1/30/2009
• Immune Tolerance Induction in Hemophilia A and B. 
  City of Hope, Duarte, CA - 1/23/2009
• Prophylaxis in Hemophilia Patients with Inhibitors. 
  Montebello, Canada - 1/6/2009
• Immune Therapy for Inhibitors. 
  Scottsdale, AZ - 1/3/2009
• Inhibitors: Overview of Key Issues. 
  Scottsdale, AZ - 1/3/2009
• Benefits of Prophylaxis in Hemophilia Patients With and Without Inhibitors. 
  Sapporo, Japan - 1/21/2008
• Prophylaxis in Hemophiliacs with Inhibitors. 
  Tokyo Medical University, Tokyo, Japan - 1/20/2008
• Prophylaxis in Patients with Hemophia A and Inhibitors. 
  St. Marianna University, Tokyo, Japan - 1/17/2008
• ITI Study Update and status of RESIST. 
  The Langham Huntington Hotel, Pasadena, CA - 1/9/2008
• Prophylaxis in patients with Hemophilia with and without Inhibitors. 
  Loma Linda University Medical Center, Loma Linda, CA - 1/3/2008
• Inhibitors in Hemophilia. An Update. 
  City of Hope, Duarte, CA - 1/15/2007
• Therapeutic Choices in the Treatment of Hemophilia. 
  Fess Parker Doubletree Resort Hotel, Santa Barbara, CA - 1/5/2007
• The FEIBA (R) NovoSeven (R) Comparative Study (FENOC). 
  Sidney, Australia - 1/1/2007
• Prophylaxis in Hemophilia Patients with Factor VIII Inhibitors. 
  Vancouver, Canada - 1/24/2006
• Therapeutic Strategies to Prevent Joint Deterioration in Children with Hemophilia and Anti Factor VIII Antibodies VIII. 
  City of Hope National Medical Center, Duarte, CA - 1/12/2006
• Rescue Immunotolerance Study (RES.I.ST). 
  Chicago, IL - 1/11/2006
• History of Hemophilia Care at City of Hope. 
  Pasadena, CA - 1/20/2005
• Overweight/ Obesity. Impact on Hemophilia: HTC and Consumer Perspectives. 
  Pasadena, CA - 1/20/2005
• Hemophilia in Children. 
  University of Irvine, Irvine, CA - 1/24/2002
• Bleeding Disorders in Children. 
  White Memorial Hospital, Los Angeles, CA - 1/8/2002
• Transfusions in Sickle Cell Disease. 
  City of Hope National Medical Center - 1/14/2001
• Use of Recombinant factor VIIa in the Treatment of Patients with Bleeding Disorders. 
  City of Hope National Medical Center, Duarte, CA - 1/9/2001
• Homozygous Alpha Thalassemia. 
  Huntington Memorial Hospital, Pasadena, CA - 1/16/1998
• Hemorrhagic Disorders in Children. 
  Huntington Memorial Hospital, Pasadena, CA - 1/28/1997
• Childhood Thrombosis. 
  Huntington Memorial Hospital, Pasadena, CA - 1/15/1997
• Join now to see all

Other

• Strategies for Life. Prophylaxis Therapy for Hemophilia Patients with Inhibitors. Series I, II, III. 
  Ewing, N.P., Stine, K.C., Series I, II, III. CME Monographs
  http://www.myinhibitorcme.com
  1/1/2007
• AIDS – An Update (Television Program) 
  Ewing, N.P., Antenna Sud, Bari, Italy
  1/22/1998
• AIDS and Hemophilia. 
  Ewing, N.P., Antenna Sud, Bari, Italy
  1/25/1985